SlideShare a Scribd company logo
1 of 2
Download to read offline
NEW PRODUCT LAUNCH!

Breakthrough in Non-Invasive
Lens Autofluorescence Detection

The CLEARPATH DS-120™ is
cleared by FDA as a tool for the
measurement of autofluorescence
by scanning the crystalline lens
of the eye with a blue light.
In independent scientific studies
published in peer-reviewed journals,
elevated autofluorescence measurements
have been linked to high levels of
advanced glycosylated end products
which accumulate in the presence of
diabetes.

Fluorescence Ratio

Fluorescence vs. Age Prediction Ratio Chart

Age
Observed fluorescence ratios from healthy eyes of 127 healthy subjects, with no cataracts, from Freedom Meditech clinical study.

Follow Us
@FreedomMeditech

MKT-005REVA
NEW PRODUCT LAUNCH!

Follow Us
@FreedomMeditech

MKT-005REVA

More Related Content

What's hot

Kala Pharmaceuticals
Kala PharmaceuticalsKala Pharmaceuticals
Kala PharmaceuticalsHealthegy
 
Japan development center
Japan development centerJapan development center
Japan development centeryahyasultan
 
Ophthalmology Innovation Showcase 2 - ReVision Optics
Ophthalmology Innovation Showcase 2 - ReVision OpticsOphthalmology Innovation Showcase 2 - ReVision Optics
Ophthalmology Innovation Showcase 2 - ReVision OpticsHealthegy
 
Vision Medicines
Vision MedicinesVision Medicines
Vision MedicinesHealthegy
 
Alcon Google Innovation
Alcon Google InnovationAlcon Google Innovation
Alcon Google InnovationHealthegy
 
Ophthalmology Innovation Showcase 2 - Refocus Group
Ophthalmology Innovation Showcase 2 - Refocus GroupOphthalmology Innovation Showcase 2 - Refocus Group
Ophthalmology Innovation Showcase 2 - Refocus GroupHealthegy
 
RPS Diagnostics
RPS DiagnosticsRPS Diagnostics
RPS DiagnosticsHealthegy
 
Sharklet Technologies, Inc.
Sharklet Technologies, Inc.Sharklet Technologies, Inc.
Sharklet Technologies, Inc.Healthegy
 
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaOphthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaHealthegy
 
Ophthalmology Innovation Showcase 2 - Presbyopia Therapies
Ophthalmology Innovation Showcase 2 - Presbyopia TherapiesOphthalmology Innovation Showcase 2 - Presbyopia Therapies
Ophthalmology Innovation Showcase 2 - Presbyopia TherapiesHealthegy
 
Transcend Medical
Transcend MedicalTranscend Medical
Transcend MedicalHealthegy
 
Posterior Segment Company Showcase - Ocular Therapeutix
Posterior Segment Company Showcase - Ocular TherapeutixPosterior Segment Company Showcase - Ocular Therapeutix
Posterior Segment Company Showcase - Ocular TherapeutixHealthegy
 

What's hot (20)

Kala Pharmaceuticals
Kala PharmaceuticalsKala Pharmaceuticals
Kala Pharmaceuticals
 
InnFocus
InnFocus InnFocus
InnFocus
 
Japan development center
Japan development centerJapan development center
Japan development center
 
Ophthalmology Innovation Showcase 2 - ReVision Optics
Ophthalmology Innovation Showcase 2 - ReVision OpticsOphthalmology Innovation Showcase 2 - ReVision Optics
Ophthalmology Innovation Showcase 2 - ReVision Optics
 
Vision Medicines
Vision MedicinesVision Medicines
Vision Medicines
 
PanOptica
PanOpticaPanOptica
PanOptica
 
Alcon Google Innovation
Alcon Google InnovationAlcon Google Innovation
Alcon Google Innovation
 
Acufocus
AcufocusAcufocus
Acufocus
 
Mati
MatiMati
Mati
 
Ophthalmology Innovation Showcase 2 - Refocus Group
Ophthalmology Innovation Showcase 2 - Refocus GroupOphthalmology Innovation Showcase 2 - Refocus Group
Ophthalmology Innovation Showcase 2 - Refocus Group
 
RPS Diagnostics
RPS DiagnosticsRPS Diagnostics
RPS Diagnostics
 
Sharklet Technologies, Inc.
Sharklet Technologies, Inc.Sharklet Technologies, Inc.
Sharklet Technologies, Inc.
 
Zepto
ZeptoZepto
Zepto
 
Graybug
GraybugGraybug
Graybug
 
Choroidale Neovaskularisation (CNV)
Choroidale Neovaskularisation (CNV)Choroidale Neovaskularisation (CNV)
Choroidale Neovaskularisation (CNV)
 
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaOphthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
 
Ophthalmology Innovation Showcase 2 - Presbyopia Therapies
Ophthalmology Innovation Showcase 2 - Presbyopia TherapiesOphthalmology Innovation Showcase 2 - Presbyopia Therapies
Ophthalmology Innovation Showcase 2 - Presbyopia Therapies
 
Transcend Medical
Transcend MedicalTranscend Medical
Transcend Medical
 
AGTC
AGTCAGTC
AGTC
 
Posterior Segment Company Showcase - Ocular Therapeutix
Posterior Segment Company Showcase - Ocular TherapeutixPosterior Segment Company Showcase - Ocular Therapeutix
Posterior Segment Company Showcase - Ocular Therapeutix
 

More from Eyefficient

Volk Pictor Plus brochure
Volk Pictor Plus brochureVolk Pictor Plus brochure
Volk Pictor Plus brochureEyefficient
 
Destined for Diabetes by Paul Karpecki, O.D.
Destined for Diabetes by Paul Karpecki, O.D.Destined for Diabetes by Paul Karpecki, O.D.
Destined for Diabetes by Paul Karpecki, O.D.Eyefficient
 
2013 Medizs Smart CP 11
2013 Medizs Smart CP 112013 Medizs Smart CP 11
2013 Medizs Smart CP 11Eyefficient
 
2013 Medizs Smart RK 11
2013 Medizs Smart RK 112013 Medizs Smart RK 11
2013 Medizs Smart RK 11Eyefficient
 
2013 Medizs Smart DR 13
2013 Medizs Smart DR 132013 Medizs Smart DR 13
2013 Medizs Smart DR 13Eyefficient
 
4. fm jdst published article 11 12
4. fm   jdst published article 11 124. fm   jdst published article 11 12
4. fm jdst published article 11 12Eyefficient
 

More from Eyefficient (6)

Volk Pictor Plus brochure
Volk Pictor Plus brochureVolk Pictor Plus brochure
Volk Pictor Plus brochure
 
Destined for Diabetes by Paul Karpecki, O.D.
Destined for Diabetes by Paul Karpecki, O.D.Destined for Diabetes by Paul Karpecki, O.D.
Destined for Diabetes by Paul Karpecki, O.D.
 
2013 Medizs Smart CP 11
2013 Medizs Smart CP 112013 Medizs Smart CP 11
2013 Medizs Smart CP 11
 
2013 Medizs Smart RK 11
2013 Medizs Smart RK 112013 Medizs Smart RK 11
2013 Medizs Smart RK 11
 
2013 Medizs Smart DR 13
2013 Medizs Smart DR 132013 Medizs Smart DR 13
2013 Medizs Smart DR 13
 
4. fm jdst published article 11 12
4. fm   jdst published article 11 124. fm   jdst published article 11 12
4. fm jdst published article 11 12
 

The Freedom-Meditech Clearpath ds 120

  • 1. NEW PRODUCT LAUNCH! Breakthrough in Non-Invasive Lens Autofluorescence Detection The CLEARPATH DS-120™ is cleared by FDA as a tool for the measurement of autofluorescence by scanning the crystalline lens of the eye with a blue light. In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products which accumulate in the presence of diabetes. Fluorescence Ratio Fluorescence vs. Age Prediction Ratio Chart Age Observed fluorescence ratios from healthy eyes of 127 healthy subjects, with no cataracts, from Freedom Meditech clinical study. Follow Us @FreedomMeditech MKT-005REVA
  • 2. NEW PRODUCT LAUNCH! Follow Us @FreedomMeditech MKT-005REVA